BRIEF published on 01/27/2026 at 16:48, 10 days 14 hours ago MHH dévoilera ses recherches sur la thérapie par plasma froid pour les applications pulmonaires. Innovation Médicale Résistance Aux Antibiotiques Viromed Medical AG Thérapie Par Plasma Froid Infections Pulmonaires
BRIEF published on 01/27/2026 at 16:48, 10 days 14 hours ago MHH to Unveil Cold Plasma Therapy Research for Lung Applications Medical Innovation Antibiotic Resistance Viromed Medical AG Cold Plasma Therapy Lung Infections
PRESS RELEASE published on 01/27/2026 at 16:43, 10 days 14 hours ago MHH to Present Scientific Findings on Cold Plasma Therapy for Pulmonary Application at Press Conference in February 2026 MHH to present groundbreaking cold plasma therapy for pulmonary application at press conference in February 2026, addressing urgent clinical need worldwide Scientific Findings Press Conference Viromed Medical AG Cold Plasma Therapy Pulmonary Application
BRIEF published on 01/19/2026 at 13:01, 18 days 17 hours ago Viromed Medical AG franchit une étape importante avec une étude pulmonaire ex vivo Recherche Médicale Viromed Medical AG Technologie Du Plasma Froid Étude Pulmonaire Ex Vivo Progrès Pharmaceutique
BRIEF published on 01/19/2026 at 13:01, 18 days 17 hours ago Viromed Medical AG Achieves Milestone with Ex-Vivo Lung Study Medical Research Viromed Medical AG Cold Plasma Technology Ex-vivo Lung Study Pharmaceutical Advancement
PRESS RELEASE published on 01/19/2026 at 12:56, 18 days 18 hours ago Correction of a release from 19/01/2026, 11:45 CET/CEST - Viromed Medical AG: Ex-vivo lung study marks milestone for research and approval Viromed Medical AG to conduct ex-vivo lung study on vital lungs in cooperation with universities for accelerated research and approval processes Medical Technology Viromed Medical AG Cold Plasma Technology Ex-vivo Lung Study Research Milestone
BRIEF published on 01/19/2026 at 11:50, 18 days 19 hours ago Viromed Medical AG Advances with Ex-Vivo Lung Study Viromed Medical AG Cold Plasma Technology Ex-vivo Lung Study Preclinical Research Acceleration Saarland University Collaboration
BRIEF published on 01/19/2026 at 11:50, 18 days 19 hours ago Viromed Medical AG fait progresser son étude pulmonaire ex vivo Viromed Medical AG Technologie Du Plasma Froid Étude Pulmonaire Ex Vivo Accélération De La Recherche Préclinique Collaboration De L'Université De La Sarre
PRESS RELEASE published on 01/19/2026 at 11:45, 18 days 19 hours ago Viromed Medical AG: Ex-vivo lung study marks milestone for research and approval Viromed Medical AG's ex-vivo lung study with Saarland University and MHH is a significant milestone for research & approval, accelerating development processes Research Approval Viromed Medical AG Cold Plasma Technology Ex-vivo Lung Study
BRIEF published on 01/15/2026 at 09:53, 22 days 21 hours ago Viromed Medical AG Transitions to Registered Shares Shareholders Stock Exchange Viromed Medical AG Registered Shares Cold Plasma Technology
Published on 02/07/2026 at 01:00, 5 hours 57 minutes ago Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 7 hours 47 minutes ago Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 8 hours 56 minutes ago Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 15 hours 27 minutes ago Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 17 hours 27 minutes ago Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange
Published on 02/06/2026 at 19:25, 11 hours 31 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 13 hours 4 minutes ago EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 17:40, 13 hours 17 minutes ago Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.01.26.
Published on 02/06/2026 at 16:55, 14 hours 1 minute ago GAC MPV Serves as Official Reception Fleet for APEC China 2026, Demonstrating the Strength of Chinese Manufacturing
Published on 02/06/2026 at 15:25, 15 hours 31 minutes ago CES 2026 Innovation Award Honoree iGarden M1 Pro Max Launches as World's First Bionic Dual-Vision Pool Cleaner
Published on 02/06/2026 at 18:22, 12 hours 34 minutes ago Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 12 hours 34 minutes ago Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 14 hours 55 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 14 hours 55 minutes ago Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 23 hours 2 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026
